(FM) Hematología
Departamento académico
Stanford University School of Medicine
Stanford, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Stanford University School of Medicine (11)
2024
-
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387
-
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
The Lancet Oncology, Vol. 25, Núm. 5, pp. e205-e216
2020
-
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion
Frontiers in Immunology, Vol. 11
2017
-
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
The Lancet, Vol. 390, Núm. 10094, pp. 555-566
-
Global position paper on cardiovascular regenerative medicine
European Heart Journal
2012
2011
-
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas
Leukemia, Vol. 25, Núm. 12, pp. 1882-1890
-
Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells
Journal of Immunology, Vol. 186, Núm. 2, pp. 807-815
2010
-
Clinical applications of reporter gene technology
Molecular Imaging with Reporter Genes (Cambridge University Press), pp. 297-314
2007
-
Hematopoietic reconstitution by multipotent adult progenitor cells: Precursors to long-term hematopoietic stem cells
Journal of Experimental Medicine, Vol. 204, Núm. 1, pp. 129-139